Moreover, recent knock-in models of BCR-ABL [51] and FLT3-ITD [52] (a third tyrosine kinase associated with myeloid malignancies) have both been shown to compromise HSC self-renewal in transplantation experiments. Here, FLT3 is linked to myeloid neoplasm.